Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

To Assess the Safety and Efficacy of Ciclesonide Applied as a Nasal Spray in the Treatment of Perennial Allergic Rhinitis (BY9010/M1-402)

ClinicalTrials.gov ID: NCT00659750

Public ClinicalTrials.gov record NCT00659750. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 11:46 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Clinical Trial to Assess the Safety and Efficacy of Ciclesonide, Applied as a Nasal Spray (200 mg Once Daily) in the Treatment of Perennial Allergic Rhinitis (PAR) in Patients 12 Years and Older

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this study is to demonstrate the efficacy of ciclesonide applied as a nasal spray once daily in patients with PAR. The secondary objectives are to evaluate Quality-of-Life and safety.

Study identification

NCT ID
NCT00659750
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
418 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2003 (Type not available)
Primary completion
May 2004 (Actual)
Completion
Apr 2005 (Actual)
Last update posted
Dec 2, 2016

2003 – 2005

United States locations

U.S. sites
23
U.S. states
13
U.S. cities
22
Facility City State ZIP Site status
Altana/Nycomed Encinitas California 92924 —
Altana/Nycomed Long Beach California 90806 —
Altana/Nycomed Los Angeles California 90025 —
Altana/Nycomed Mission Viejo California 92691 —
Altana/Nycomed San Diego California 92123 —
Altana/Nycomed San Jose California 95117 —
Altana/Nycomed Colorado Springs Colorado 80907 —
Altana/Nycomed Denver Colorado 80206 —
Altana/Nycomed Denver Colorado 80230 —
Altana/Nycomed Jupiter Florida 33458 —
Altana/Nycomed Rockville Maryland 20850 —
Altana/Nycomed North Dartmouth Massachusetts 02747 —
Altana/Nycomed Minneapolis Minnesota 55402 —
Altana/Nycomed St Louis Missouri 63141 —
Altana/Nycomed Missoula Montana 59804 —
Altana/Nycomed Brick New Jersey 08724 —
Altana/Nycomed Skillman New Jersey 08558 —
Altana/Nycomed Raleigh North Carolina 27607 —
Altana/Nycomed Winston-Salem North Carolina 27103 —
Altana/Nycomed Sylvania Ohio 43560 —
Altana/Nycomed Fort Worth Texas 76132 —
Altana/Nycomed Houston Texas 77084 —
Altana/Nycomed Madison Wisconsin 53792-9988 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00659750, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 2, 2016 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00659750 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →